maintenance therapy
Showing 9976 - 10000 of >10,000
Symptom Distress and Cancer-related Fatigue After Adjuvant
Not yet recruiting
- Symptom Distress During Breast Cancer Treatment
- breast adenocarcinoma receiving chemotherapy
- Control-for
- (no location specified)
May 28, 2021
Stroke Syndrome, Hemiplegia Trial in White Plains (Rapael)
Withdrawn
- Stroke Syndrome
- Hemiplegia
- Rapael
-
White Plains, New YorkBurke rehabilitation Hospital
May 4, 2022
Rheumatoid Arthritis Trial in Worldwide (Non-biological DMARD's, Cimzia, Orencia)
Active, not recruiting
- Rheumatoid Arthritis
- Non-biological DMARD's
- +3 more
-
Aalborg, Denmark
- +29 more
Jul 7, 2022
Chemo-Induced Peripheral Neuropathy, Malignant Tumor Trial in Houston (device, other, procedure)
Completed
- Chemotherapy-Induced Peripheral Neuropathy
- Malignant Neoplasm
- FitBit
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Mar 22, 2022
Atrial Fibrillation, Persistent, Atrial Fibrillation, Arrhythmias, Cardiac Trial in United States (Ablamap Software)
Not yet recruiting
- Atrial Fibrillation, Persistent
- +5 more
- Ablamap Software
-
Birmingham, Alabama
- +3 more
Jul 28, 2022
Non-healing Wounds and Implication of Remote Monitoring and
Active, not recruiting
- Non-healing Wounds
- Natrox Topical Oxygen Therapy
-
Roanoke, VirginiaSalem VA Healthcare
Jul 29, 2022
ADHD Trial in United States (AKL-T01)
Active, not recruiting
- Attention Deficit Hyperactivity Disorder
- AKL-T01
-
Scottsdale, Arizona
- +13 more
Jul 28, 2022
Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia Trial in United States (Memantine, Placebo (for Memantine))
Completed
- Amyotrophic Lateral Sclerosis
- Frontal Temporal Dementia
- Memantine
- Placebo (for Memantine)
-
Phoenix, Arizona
- +12 more
Nov 8, 2022
Edentulous Mouth, Edentulous Jaw Trial in Montreal (mandibular implant-overdenture)
Not yet recruiting
- Edentulous Mouth
- Edentulous Jaw
- mandibular implant-overdenture
-
Montreal, Quebec, CanadaMcGill University, Faculty of Dentistry
Nov 30, 2023
NSCLC Trial (Dupilumab, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Dupilumab
- Cemiplimab
- (no location specified)
Oct 12, 2023
Coronary Artery Disease Trial in Seoul (Clopidogrel monotherapy, Tailored anti-platelet therapy)
Not yet recruiting
- Coronary Artery Disease
- Clopidogrel monotherapy
- Tailored anti-platelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital
Jul 3, 2023
Weight Trajectory Trial in San Francisco (gamma-linolenic acid, )
Active, not recruiting
- Weight Trajectory
- gamma-linolenic acid
- placebo
-
San Francisco, CaliforniaVirta Health
Mar 29, 2021
Motivation for Exercise and Physical Activity Adherence
Completed
- Obesity
- MOVE
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jun 15, 2021
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
-
Anchorage, Alaska
- +12 more
Nov 3, 2022
High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle
Terminated
- High Grade Anal Canal Intraepithelial Neoplasia
- High Grade Vulvar Squamous Intraepithelial Lesion
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +1 more
Jan 24, 2023
Complications of MidLine Catheters in the ICU
Recruiting
- Catheter Complications
-
Le Mans, FranceCentre Hospitalier Du Mans
Jun 7, 2022
NSCLC Trial in Cleveland (Durvalumab, Proton beam therapy RT)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Durvalumab
- Proton beam therapy RT
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 5, 2022
Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)
Not yet recruiting
- Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Nivolumab
- +2 more
- (no location specified)
Aug 10, 2022
Diabetes, Blood Sugar; High Trial in Guangzhou (Meal Replacement)
Recruiting
- Diabetes
- Blood Sugar; High
- Meal Replacement
-
Guangzhou, Guangdong, Chinathe First Affiliated Hospital of Sun Yat-sen University
May 6, 2022
Hepatocellular Carcinoma Trial (HAIC(FOLFOX), Oxaliplatin, Leucovorin)
Not yet recruiting
- Hepatocellular Carcinoma
- HAIC(FOLFOX)
- +5 more
- (no location specified)
Aug 16, 2022
Type 1 Diabetes, Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Not yet recruiting
- Type 1 Diabetes
- Diabetes
- LY3209590
- Insulin Degludec
-
Concord, California
- +86 more
Aug 17, 2022